drugset / Trial / NCT02487550
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.
Timeline
- Start
- 2015-08
- Primary completion
- 2028-07
- Completion
- 2030-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CIK cells | Cell therapy | — | Intravenous |
| Subject | Dendritic cells | Cell therapy | — | Other |
| Subject | IFN-α | Unknown | — | Intravenous |
| Subject | aldesleukin | Protein / enzyme biologic | — | Intravenous |